Achievable logoAchievable logo
CCMA
Sign in
Sign up
Purchase
Textbook
Practice exams
Support
How it works
Exam catalog
Mountain with a flag at the peak
Textbook
1. Medical assistant
2. Electronic records
3. Medical terminology and anatomy
4. The fundamentals of infection control
5. Introduction to vital signs
6. The patient interview and history
7. The physical examination
8. Appointment scheduling
9. Insurance billing
10. Diagnostic coding and the ICD-10-CM System
11. Procedural coding
12. Medical billing and reimbursement essentials
13. Assisting with medical specialties
14. Assisting with the musculoskeletal system
15. Assisting with the cardiovascular system
16. Assisting with the respiratory system
17. Assisting with the nervous system
18. Anatomy and physiology of the urinary system
19. Assisting in obstetrics and gynecology
20. Assisting in endocrinology
21. Assisting in ophthalmology & otolaryngology
22. Assisting in gastroenterology
23. Assisting in the immune & lymphatic systems
24. Assisting in pediatrics: the developmental stages and care
25. The medical assistant’s role in caring for the older patient
26. The role of the medical assistant in physical therapy examination and assessment
27. Preparing for minor surgery: room, solutions, and supplies
28. Introduction to the clinical laboratory
29. Urinalysis
29.1 Urine formation and specimen collection
29.2 Physical examination of urine
29.3 Chemical examination of urine
29.4 Additional CLIA-waived urine tests
29.5 Microscopic preparation of urine and cellular findings
29.6 Urine toxicology, legal issues, and professional practice
30. Blood collection
31. Analysis of blood
32. Electrocardiography and heart structure
33. The principles of pharmacology
34. Essential calculations and measurement systems
35. Solid, liquid, & solutions medication doses
36. Administering medications
37. Metabolism and core nutrient roles
38. Medical emergencies in the healthcare setting
Achievable logoAchievable logo
29.4 Additional CLIA-waived urine tests
Achievable CCMA
29. Urinalysis
Our CCMA course is currently in development and is a work-in-progress.

Additional CLIA-waived urine tests

5 min read
Font
Discuss
Share
Feedback

In addition to a routine urinalysis, there are other tests that can be done on urine. Medical assistants can perform CLIA-waived urine tests, and some of those are discussed in the following sections. Urine can also be used for toxicology testing. It is important for anyone working with specimens for toxicology to have an understanding of how those specimens could potentially be adulterated and to understand the chain of command. This is also discussed in the following section.

Urine pregnancy testing

All pregnancy tests detect the presence of human chorionic gonadotropin (hCG), a hormone produced by the placenta and present in urine during pregnancy (see Procedure 32.7). After the fertilized egg has implanted in the uterus, the hCG levels in serum double every few days. This rapid rise occurs for approximately 7 weeks, and then the level begins to decline. Within 72 hours of delivery, the hormone disappears.

The most common type of test for pregnancy is the lateral flow immunoassay test. Many brands are available for laboratory use and are also available over the counter (OTC) for home use. These tests are sensitive enough to detect the presence of hCG in urine as early as 1 week after implantation, or 4 to 5 days before a missed menstrual period. The tests can be performed in as little as 5 minutes and are easy to interpret. CLIA-waived pregnancy tests or home pregnancy tests are read following the manufacturer’s instructions. Evaluating the results is often as simple as reading a color change. For optimum results, the test should be performed on a first-morning urine specimen because it is the most concentrated urine of the day.

The test is based on reactions that occur between antibodies and antigens. Antibodies are proteins formed in response to a specific antigen (e.g., paired like a lock and key). Antigens are foreign substances that initiate the production of antibodies. When antibodies and antigens come in contact, the antibody binds to the antigen. This makes the antigen unable to cause disease. (See Chapter 18 for more information on antibodies and antigens.)

The pregnancy test cartridge contains a membrane with an absorbent pad. The urine sample is pipetted into the sample well of the test cartridge. The urine then moves along the absorbent pad, reaching the test area on the membrane. The following reactions can occur:

  • All samples (positive or negative) cause the control zone © line to turn blue. The presence of this line indicates that the test has been carried out correctly. If the C control zone does not show a color reaction, the test is considered invalid (incorrect) and must be repeated using another test device.
  • In a positive sample, the hCG antigen attaches to the antibodies in the test zone (T), forming a pink line.
  • In a negative sample, there is no hCG antigen to attach to the antibodies in the test zone (T), and no line forms.

The Quick Vue test is a lateral flow pregnancy test that can be performed on urine. It is used routinely in many POLs.

Ovulation testing

CLIA-waived lateral flow urine tests are available to predict ovulation for women attempting to conceive either naturally or using artificial insemination . During the menstrual cycle, luteinizing hormone (LH) remains at a relatively stable level. Approximately 14 days before menstruation, the body experiences the “LH surge,” a brief, rapid increase in LH. This surge triggers the release of an ovum (egg) from the ovary. Two to 3 days after the surge, the LH level returns to the base level. Conception is most likely to occur within 36 hours after the LH surge. The principle behind this test is similar to that of the pregnancy test. The absorbent membrane contains anti-LH antibodies. A positive test result indicates a urine LH level of 20 mIU/mL or higher. Testing usually is performed for 5 consecutive days in the middle of a woman’s cycle. Once the surge is detected, ovulation can be expected within 2 to 3 days.

Menopause testing

A woman is said to have reached menopause when she has not had a menstrual period for at least 12 months. The time before menopause, called perimenopause, can last for years, bringing with it uncomfortable symptoms such as irregular periods, hot flashes, vaginal dryness, and sleep problems.

Some of this may be due to an increase in follicle-stimulating hormone (FSH). Levels of FSH increase temporarily each month to stimulate the ovaries to produce an ovum (egg). When a woman enters menopause, the ovaries stop producing eggs, and the levels of FSH rise. CLIA-waived lateral flow tests detect FSH in the urine. A positive test result indicates that a woman may be in menopause; a negative test result, along with symptoms of menopause, may indicate that a woman is in perimenopause.

The qualitative lateral flow test should never be used to direct a woman to stop using birth control methods if she does not want to conceive. Pregnancy is still possible during perimenopause.

Commonly abused drugs and body retention times

Drug Retention time
Alcohol 2–10 hours
Amphetamine 24–48 hours
Methamphetamine 3–5+ days
Barbiturates
— Phenobarbital 2–6 days
— Secobarbital 24 hours
Cocaine, cocaine metabolites 12 hours–3 days
Opiates, heroin, morphine 3–4 days
Phencyclidine (PCP) 3–7+ days
Marijuana (tetrahydrocannabinol metabolites) 2 days up to 11 weeks (for daily users)
Oxycodone 3 days

CLIA-waived urine tests overview

  • Performed by medical assistants in addition to routine urinalysis
  • Includes pregnancy, ovulation, menopause, and toxicology tests
  • Importance of understanding specimen adulteration and chain of custody in toxicology

Urine pregnancy testing

  • Detects human chorionic gonadotropin (hCG) hormone
  • Uses lateral flow immunoassay; results in ~5 minutes
  • Positive: pink line in test zone (T); negative: no line; control © line must appear

Ovulation testing

  • Detects luteinizing hormone (LH) surge indicating ovulation
  • Positive test: LH ≥ 20 mIU/mL; ovulation likely within 36 hours
  • Testing performed mid-cycle for 5 consecutive days

Menopause testing

  • Detects follicle-stimulating hormone (FSH) in urine
  • Positive: elevated FSH, suggests menopause; negative with symptoms may indicate perimenopause
  • Not to be used as sole indicator to stop birth control

Commonly abused drugs and retention times

  • Alcohol: 2–10 hours
  • Amphetamine: 24–48 hours
  • Methamphetamine: 3–5+ days
  • Barbiturates:
    • Phenobarbital: 2–6 days
    • Secobarbital: 24 hours
  • Cocaine/metabolites: 12 hours–3 days
  • Opiates/heroin/morphine: 3–4 days
  • Phencyclidine (PCP): 3–7+ days
  • Marijuana (THC metabolites): 2 days–11 weeks (daily users)
  • Oxycodone: 3 days

Sign up for free to take 7 quiz questions on this topic

Previous
Next  | 29.5 Microscopic preparation of urine and cellular findings
All rights reserved ©2016 - 2026 Achievable, Inc.

Additional CLIA-waived urine tests

In addition to a routine urinalysis, there are other tests that can be done on urine. Medical assistants can perform CLIA-waived urine tests, and some of those are discussed in the following sections. Urine can also be used for toxicology testing. It is important for anyone working with specimens for toxicology to have an understanding of how those specimens could potentially be adulterated and to understand the chain of command. This is also discussed in the following section.

Urine pregnancy testing

All pregnancy tests detect the presence of human chorionic gonadotropin (hCG), a hormone produced by the placenta and present in urine during pregnancy (see Procedure 32.7). After the fertilized egg has implanted in the uterus, the hCG levels in serum double every few days. This rapid rise occurs for approximately 7 weeks, and then the level begins to decline. Within 72 hours of delivery, the hormone disappears.

The most common type of test for pregnancy is the lateral flow immunoassay test. Many brands are available for laboratory use and are also available over the counter (OTC) for home use. These tests are sensitive enough to detect the presence of hCG in urine as early as 1 week after implantation, or 4 to 5 days before a missed menstrual period. The tests can be performed in as little as 5 minutes and are easy to interpret. CLIA-waived pregnancy tests or home pregnancy tests are read following the manufacturer’s instructions. Evaluating the results is often as simple as reading a color change. For optimum results, the test should be performed on a first-morning urine specimen because it is the most concentrated urine of the day.

The test is based on reactions that occur between antibodies and antigens. Antibodies are proteins formed in response to a specific antigen (e.g., paired like a lock and key). Antigens are foreign substances that initiate the production of antibodies. When antibodies and antigens come in contact, the antibody binds to the antigen. This makes the antigen unable to cause disease. (See Chapter 18 for more information on antibodies and antigens.)

The pregnancy test cartridge contains a membrane with an absorbent pad. The urine sample is pipetted into the sample well of the test cartridge. The urine then moves along the absorbent pad, reaching the test area on the membrane. The following reactions can occur:

  • All samples (positive or negative) cause the control zone © line to turn blue. The presence of this line indicates that the test has been carried out correctly. If the C control zone does not show a color reaction, the test is considered invalid (incorrect) and must be repeated using another test device.
  • In a positive sample, the hCG antigen attaches to the antibodies in the test zone (T), forming a pink line.
  • In a negative sample, there is no hCG antigen to attach to the antibodies in the test zone (T), and no line forms.

The Quick Vue test is a lateral flow pregnancy test that can be performed on urine. It is used routinely in many POLs.

Ovulation testing

CLIA-waived lateral flow urine tests are available to predict ovulation for women attempting to conceive either naturally or using artificial insemination . During the menstrual cycle, luteinizing hormone (LH) remains at a relatively stable level. Approximately 14 days before menstruation, the body experiences the “LH surge,” a brief, rapid increase in LH. This surge triggers the release of an ovum (egg) from the ovary. Two to 3 days after the surge, the LH level returns to the base level. Conception is most likely to occur within 36 hours after the LH surge. The principle behind this test is similar to that of the pregnancy test. The absorbent membrane contains anti-LH antibodies. A positive test result indicates a urine LH level of 20 mIU/mL or higher. Testing usually is performed for 5 consecutive days in the middle of a woman’s cycle. Once the surge is detected, ovulation can be expected within 2 to 3 days.

Menopause testing

A woman is said to have reached menopause when she has not had a menstrual period for at least 12 months. The time before menopause, called perimenopause, can last for years, bringing with it uncomfortable symptoms such as irregular periods, hot flashes, vaginal dryness, and sleep problems.

Some of this may be due to an increase in follicle-stimulating hormone (FSH). Levels of FSH increase temporarily each month to stimulate the ovaries to produce an ovum (egg). When a woman enters menopause, the ovaries stop producing eggs, and the levels of FSH rise. CLIA-waived lateral flow tests detect FSH in the urine. A positive test result indicates that a woman may be in menopause; a negative test result, along with symptoms of menopause, may indicate that a woman is in perimenopause.

The qualitative lateral flow test should never be used to direct a woman to stop using birth control methods if she does not want to conceive. Pregnancy is still possible during perimenopause.

Commonly abused drugs and body retention times

Drug Retention time
Alcohol 2–10 hours
Amphetamine 24–48 hours
Methamphetamine 3–5+ days
Barbiturates
— Phenobarbital 2–6 days
— Secobarbital 24 hours
Cocaine, cocaine metabolites 12 hours–3 days
Opiates, heroin, morphine 3–4 days
Phencyclidine (PCP) 3–7+ days
Marijuana (tetrahydrocannabinol metabolites) 2 days up to 11 weeks (for daily users)
Oxycodone 3 days
Key points

CLIA-waived urine tests overview

  • Performed by medical assistants in addition to routine urinalysis
  • Includes pregnancy, ovulation, menopause, and toxicology tests
  • Importance of understanding specimen adulteration and chain of custody in toxicology

Urine pregnancy testing

  • Detects human chorionic gonadotropin (hCG) hormone
  • Uses lateral flow immunoassay; results in ~5 minutes
  • Positive: pink line in test zone (T); negative: no line; control © line must appear

Ovulation testing

  • Detects luteinizing hormone (LH) surge indicating ovulation
  • Positive test: LH ≥ 20 mIU/mL; ovulation likely within 36 hours
  • Testing performed mid-cycle for 5 consecutive days

Menopause testing

  • Detects follicle-stimulating hormone (FSH) in urine
  • Positive: elevated FSH, suggests menopause; negative with symptoms may indicate perimenopause
  • Not to be used as sole indicator to stop birth control

Commonly abused drugs and retention times

  • Alcohol: 2–10 hours
  • Amphetamine: 24–48 hours
  • Methamphetamine: 3–5+ days
  • Barbiturates:
    • Phenobarbital: 2–6 days
    • Secobarbital: 24 hours
  • Cocaine/metabolites: 12 hours–3 days
  • Opiates/heroin/morphine: 3–4 days
  • Phencyclidine (PCP): 3–7+ days
  • Marijuana (THC metabolites): 2 days–11 weeks (daily users)
  • Oxycodone: 3 days

More from Urinalysis

  • Urine formation and specimen collection
  • Physical examination of urine
  • Chemical examination of urine
  • Microscopic preparation of urine and cellular findings
  • Urine toxicology, legal issues, and professional practice